HBI 2025
Log in
Language
Resource center
Contact app support
Legal
Home
Re-watch HBI 2025
HBI 2025 Speakers
Our Partners
The disruptive role of AI and Real World Evidence in delivering 4P Medicine, Imane Moest, Roche
Presentations
Add to my wish list
Information
Click this link to download presentation
https://www.healthcarebusinessinternational.com/wp-content/uploads/Imane-Moest_Roche_The-disruptive-role-of-AI-and-Real-World-Evidence-in-delivering-4P-Medicine_HBI-2025.pdf
Roche
Roche Meeting Suite - C2
Founded in 1896 in Basel, Switzerland, as one of the first industrial manufacturers of branded medicines, Roche has grown into the world’s largest biotechnology company and the global leader in in-vitro diagnostics. The company pursues scientific excellence to discover and develop medicines and diagnostics for improving and saving the lives of people around the world. We are a pioneer in personalised healthcare and want to further transform how healthcare is delivered to have an even greater impact. To provide the best care for each person we partner with many stakeholders and combine our strengths in Diagnostics and Pharma with data insights from the clinical practice. In recognising our endeavour to pursue a long-term perspective in all we do, Roche has been named one of the most sustainable companies in the pharmaceuticals industry by the Dow Jones Sustainability Indices for the thirteenth consecutive year. This distinction also reflects our efforts to improve access to healthcare together with local partners in every country we work. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan.
Log in
See all the content and easy-to-use features by logging in or registering!
Log in
Continue as a guest